<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01354106</url>
  </required_header>
  <id_info>
    <org_study_id>EM-05-012247</org_study_id>
    <nct_id>NCT01354106</nct_id>
  </id_info>
  <brief_title>Adhesive Tape Trauma Evaluation of Two Gentle Tapes</brief_title>
  <official_title>Adhesive Tape Trauma Evaluation of Two Gentle Tapes in Healthy Human Infant Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>3M</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>3M</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the relative gentleness of two tapes recognized
      for gentleness. A three-prong multidimensional evaluation consisting of laboratory
      assessments, expert skin grader and subject discomfort assessment will be used.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to determine the relative gentleness of a new investigational
      tape compared to 3M Micropore tape, a gold standard tape recognized for its gentleness and
      used as a mainstay in cosmetic surgery and neonatal care. A three-prong multidimensional
      evaluation consisting of laboratory assessments, expert skin grader and subject discomfort
      assessment will be used.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Skin Trauma</measure>
    <time_frame>24 hours</time_frame>
    <description>Expert grader using Erythema/Edema Scale 0=No visible response
mild response
moderate response
severe response
extreme response</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Adhesive Tape Trauma</condition>
  <arm_group>
    <arm_group_label>3M Kind Removal Silicone Tape</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>investigational medical Silicone tape, 1&quot; x 1.5&quot; sample, applied on time, worn for 24 hours.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3M Micropore Medical Tape</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Commercially available Medical Paper Tape, 1&quot; x 1.5&quot; sample, applied on time, worn for 24 hours. Study Control.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Skin Trauma</intervention_name>
    <description>Each participant completed received both treatment arms, the 3M Micropore and 3M Kind Removal Silicone Tape.</description>
    <arm_group_label>3M Kind Removal Silicone Tape</arm_group_label>
    <arm_group_label>3M Micropore Medical Tape</arm_group_label>
    <other_name>3M Micropore</other_name>
    <other_name>3M Kind Removal Silicone Tape - Investigational tape</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Who are healthy and who have intact skin at the test site with a baseline score of 0
             for erythema

          2. Who are between the ages of 6 months - 4 years of age

          3. Who has a Fitzpatrick Skin Type of I, II or III

          4. Subject who's parent agrees to not use any products (i.e. topical medications, creams,
             powders or ointments) on the test sites for 24 hours prior to the study start date

          5. Whose parent is willing to sign the Informed Consent Form.

        Exclusion Criteria:

          1. Who are known to be developmentally delayed

          2. Who have sunburn, skin infection or scars, moles, or other blemishes on the back that
             would obscure grading of the test sites

          3. Who have had any exposure to other topical medications, creams, powders, or ointments
             on the test sites 24 hours prior to the start of the study.

          4. Who have had a strep infection within the past 2 weeks

          5. Who have a history of diabetes, psoriasis, any active dermatitis, or recent history of
             dermatitis or skin reactions

          6. Who have allergies to isocyanates, or acrylate adhesive products

          7. Who currently take any antihistamines or anti-inflammatory medication or who have
             taken any of these medications within 48 hours prior to the start of the study or does
             not agree to refrain from taking these medications for the 48 hours prior to the start
             of the study and for the duration of the study (Tylenol is an acceptable pain
             reliever).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Months</minimum_age>
    <maximum_age>4 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary L Grove, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>cyberDERM</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>cyberDERM</name>
      <address>
        <city>Broomall</city>
        <state>Pennsylvania</state>
        <zip>19008</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2011</study_first_submitted>
  <study_first_submitted_qc>May 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2011</study_first_posted>
  <results_first_submitted>July 20, 2012</results_first_submitted>
  <results_first_submitted_qc>October 10, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">October 12, 2012</results_first_posted>
  <last_update_submitted>October 10, 2012</last_update_submitted>
  <last_update_submitted_qc>October 10, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 12, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Skin condition after wear</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Wounds and Injuries</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>recruitment started May 16, 2011 at cyberDERM</recruitment_details>
      <pre_assignment_details>participant not to use any products on the test sites for 24 hours prior to the study state date.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Adhesive Medical Tape</title>
          <description>Each study participant received both treatment arms: 3M Kind Removal Silicone Tape (1&quot; x 1.5&quot; sample, applied one time, worn 24 hours) and 3M Micropore Silicone Tape (1&quot; x 1.5&quot; sample, applied one ime, worn 24 hours).</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="26"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="24"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Infant</title>
          <description>Investigational adhesive tape control paper tape</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="26"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2.88" spread="0.87"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Skin Trauma</title>
        <description>Expert grader using Erythema/Edema Scale 0=No visible response
mild response
moderate response
severe response
extreme response</description>
        <time_frame>24 hours</time_frame>
        <group_list>
          <group group_id="O1">
            <title>3M Kind Removal Silicone Tape</title>
            <description>1&quot; x 1.5&quot; sample applied one time, worn for 24 hours.</description>
          </group>
          <group group_id="O2">
            <title>3M Micropore Medical Tape</title>
            <description>1&quot; x 1.5&quot; sample applied one time, worn for 24 hours.</description>
          </group>
        </group_list>
        <measure>
          <title>Skin Trauma</title>
          <description>Expert grader using Erythema/Edema Scale 0=No visible response
mild response
moderate response
severe response
extreme response</description>
          <units>Units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="24"/>
                <count group_id="O2" value="24"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.93" spread="0.14"/>
                    <measurement group_id="O2" value="1.35" spread="0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Investigational Adhesive Tape</title>
        </group>
        <group group_id="E2">
          <title>Control Paper Tape</title>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="26"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="26"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The proposed disclosure must be reviewed by the sponsor. The sponsor shall complete the review within 30 working days after receipt. The PI will discuss and consider in good faith the sponsor recommendations resulting from the review.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Gary Grove</name_or_title>
      <organization>cyberDERM</organization>
      <phone>610-325-0112</phone>
      <email>GGrove@cyberderm-inc.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

